ELECTRA THERAPEUTICS INC ETRA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$619.5K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 42.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 1.15% to 0.79% of float over the last 3 biweekly reports (30 Sep 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +7,449,857 | 11.9% |
| Westlake Village BioPartners | VC/PE Fund | 2026/Q3 | +6,347,539 | 10.1% |
| Eqt Fund Management S.à R.L. | VC/PE Fund | 2026/Q3 | +3,795,281 | 6.0% |
| Sanofi | Public Company | 2026/Q3 | +2,461,948 | 3.9% |
| Jefferies Financial Group Inc. | Public Company | 2026/Q3 | +2,244,333 | 3.6% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +2,055,706 | 3.3% |
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +499,408 | 0.8% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +417,567 | 0.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +225,156 | 0.4% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q3 | +177,688 | 0.3% |
| Ensign Peak Advisors Inc. | Endowment Fund | 2026/Q3 | +158,371 | 0.3% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +127,942 | 0.2% |
| Monashee Investment Management, LLC | Hedge Fund | 2026/Q3 | +100,000 | 0.2% |
| Y-Intercept (Hong Kong) Limited | Mutual Fund | 2026/Q3 | +21,103 | 0.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +18,205 | 0.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | OrbiMed Advisors LLC | Open Market Acquisition | +92,116 | $8.45 | 7,449,857 | |
| 4 Nov 2026 | OrbiMed Advisors LLC | Open Market Acquisition | +472,571 | $7.88 | 7,357,741 | |
| 20 Sep 2026 | OrbiMed Advisors LLC | Private Acquisition | +1,333,333 | $15.00 | 6,885,170 | |
| 20 Sep 2026 | OrbiMed Advisors LLC | Derivative Exercise and Retained | +5,551,837 | – | 6,885,170 | |
| 20 Sep 2026 | Nancy Stagliano | Independent Chairperson | Derivative Exercise and Retained | +255,635 | – | 255,635 |
| 20 Sep 2026 | Graham Parry | Chief Scientific Officer | Derivative Exercise and Retained | +85,504 | – | 85,504 |
| 20 Sep 2026 | Quehuong Dong | Chief Executive Officer | Derivative Exercise and Retained | +455,484 | – | 455,484 |
| 20 Sep 2026 | Westlake Village BioPartners | Initial Statement of Beneficial | +0 | – | 6,347,539 | |
| 20 Sep 2026 | Gary Koe | Chief Technology Officer | Derivative Exercise and Retained | +63,656 | – | 63,656 |
| 17 Sep 2026 | Carl Gordon | Independent Director | Initial Statement of Beneficial | +0 | – | 22,632 |
| 17 Sep 2026 | Matthew Fust | Independent Director | Initial Statement of Beneficial | +0 | – | 159,432 |
| 17 Sep 2026 | David Tucker | Senior VP of Finance & Principal Accounting Officer | Initial Statement of Beneficial | +0 | – | 187,402 |
| 17 Sep 2026 | Nancy Stagliano | Independent Chairperson | Initial Statement of Beneficial | +0 | – | 288,814 |
| 17 Sep 2026 | Graham Parry | Chief Scientific Officer | Initial Statement of Beneficial | +0 | – | 187,402 |
| 17 Sep 2026 | Quehuong Dong | Chief Executive Officer | Initial Statement of Beneficial | +0 | – | 2,298,219 |
| 17 Sep 2026 | Kim-Hien Dao | Chief Medical Officer | Initial Statement of Beneficial | +0 | – | 703,181 |
| 17 Sep 2026 | Gary Koe | Chief Technology Officer | Initial Statement of Beneficial | +0 | – | 548,616 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 484,020 | 0.8% | 1.7 |
| 15 Oct 2026 | 409,380 | 0.7% | 1.0 |
| 30 Sep 2026 | 702,266 | 1.1% | 1.0 |
No comments yet — be the first to weigh in on ETRA.
Sign in to join the discussion.